Docetaxel (as generic or under the trade name Taxotere or Docefrez) is a clinically well-established anti-mitotic chemotherapy medication that works by interfering with cell division. Docetaxel is approved by the FDA for treatment of locally advanced or metastatic breast cancer head and neck cancer gastric cancer hormone-refractory prostate cancer and non small-cell lung cancer.
This page contains content from the copyrighted Wikipedia article "Docetaxel"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
